Oric Pharmaceuticals (ORIC) Cash & Equivalents (2019 - 2026)
Oric Pharmaceuticals (ORIC) reported Cash & Equivalents of $37.48 million for Q2 2026, down 50.6% from $75.86 million a year earlier and down 33.5% from the prior quarter.
Powered by 
Analysis
Oric Pharmaceuticals (ORIC) Cash & Equivalents (2019 - 2026) Analysis & Trends
At the end of FY2025, Oric Pharmaceuticals posted Cash & Equivalents of $45.67 million, down 23.1% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of -10.3% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $59.41 million in FY2024 (+154.0%), $23.38 million in FY2023 (-65.0%), $66.84 million in FY2022 (-70.4%) and $226.01 million in FY2021 (+188.1%).
- The Q2 2026 figure ranks as the lowest quarterly Cash & Equivalents since Q4 2023.
- Year over year, Cash & Equivalents gained in five of the last eight quarters, with growth averaging 26.9%.
- The high point for year-over-year Cash & Equivalents in five years was Q3 2021 (growth of 288.7%); the low point was Q3 2022 (a decline of 87.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $56.4 million (Q1 2026), $45.67 million (Q4 2025) and $49.67 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Oric Pharmaceuticals | 1.26 Bn | 1.26 Bn | - | 37.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.48 Mn |
| Mar 31, 2026 | 56.40 Mn |
| Dec 31, 2025 | 45.67 Mn |
| Sep 30, 2025 | 49.67 Mn |
| Jun 30, 2025 | 75.86 Mn |
| Mar 31, 2025 | 49.33 Mn |
| Dec 31, 2024 | 59.41 Mn |
| Sep 30, 2024 | 44.23 Mn |
| Jun 30, 2024 | 49.83 Mn |
| Mar 31, 2024 | 56.36 Mn |
| Dec 31, 2023 | 23.38 Mn |
| Sep 30, 2023 | 26.24 Mn |
| Jun 30, 2023 | 103.68 Mn |
| Mar 31, 2023 | 58.99 Mn |
| Dec 31, 2022 | 66.84 Mn |
| Sep 30, 2022 | 29.08 Mn |
| Jun 30, 2022 | 49.08 Mn |
| Mar 31, 2022 | 112.64 Mn |
| Dec 31, 2021 | 226.01 Mn |
| Sep 30, 2021 | 241.13 Mn |
API Access
Oric Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ORIC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ORIC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ORIC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();